Collaborating with colleagues from UBC and UCLA, BC-CfE researchers, in a novel study, looked at whether people living with HIV (PLWH) and (COPD) experience an acceleration of aging in their airways, independent of their smoking history.
In what’s believed to be a first of its kind analysis, BC-CfE researchers evaluated patient reported HIV care experiences and therapeutic outcomes prior to, and after, implementation of BC’s Treatment as Prevention¨ (TasP¨) designed Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) program.
Dr. Brumme is an inspiring leader who is full of energy and passion. I had the opportunity to work with her at the start of the pandemic and she has been most helpful and insightful with the research and clinical teams. I look forward to learning more from her.
In late April the Canadian Association for HIV Research (CAHR) held its annual conference. With more than 1,000 members, CAHR is the leading organization of HIV/AIDS researchers in Canada. The theme for this year’s virtual conference was “Striving Towards Equity and Flourishing in the HIV Response”. In choosing the theme, organizers of the conference compared the decades-long fight for equitable distribution of antiretroviral therapy (ART) to the distribution of COVID-19 vaccines, and the massive disparities seen between high and low-income countries in both.
On May 27th, 2014, eight years ago today, the BC Centre for Excellence in HIV/AIDS and Providence Health Care closed the dedicated HIV/AIDS inpatient unit at St. Paul’s Hospital, known as ward 10C, and repurposed it into an urban health unit. This was a historic landmark, as Vancouver became the first city in the world to repurpose its AIDS ward
Schizophrenia affects more than 24 million people worldwide according to the World Health Organization. Common symptoms include thinking disorder, delusions, hallucinations, and negative syndrome, which induces severe loss of interest and social isolation. The term schizophrenia literally means “a splitting of the mind” and was coined in 1908 by Swiss psychiatrist Dr. Paul Eugen Bleuler.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
